XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
6.38
+0.04 (0.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $194.48 million as of December 20, 2024. Its market cap has increased by 52.90% in one year.
Market Cap
194.48M
Enterprise Value
21.37M
1-Year Change
52.90%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $194.48M, a decrease of -73.63%. That is a compound annual growth rate of -12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 194.50M | 59.82% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 199.59M |
| Inventiva | 198.65M |
| Mersana Therapeutics | 197.65M |
| Stereotaxis | 195.73M |
| Organigram Holdings | 194.87M |
| Perspective Therapeutics | 192.62M |
| Cybin | 192.21M |
| Inozyme Pharma | 192.08M |